ProPhet

ProPhet Overview

ProPhet is an AI-driven company transforming small molecule drug discovery, with a focus on proteins that are hard to target using competitive methods. The company develops advanced technology to identify potential therapeutics for these challenging targets, addressing a critical need in the pharmaceutical industry. Its innovative approach leverages artificial intelligence and machine learning to speed up and enhance the early stages of drug discovery. By predicting protein dynamics and how they interact with drug candidates, ProPhet can rapidly identify promising molecules. This allows to tackle proteins with limited structural information, opening new possibilities for treating diseases previously considered “undruggable.” ProPhet stands out by combining speed, precision, and scientific rigor. Its AI platform evaluates vast libraries of small molecules, offering faster, more efficient, and cost-effective solutions compared to both traditional and other AI-based methods. By doing so, it helps pharmaceutical companies and researchers explore a broader range of treatments with more accuracy, backed by scientifically interpretable results. Its vision is to revolutionize drug discovery, making it faster and more accessible. ProPhet aims to deliver better solutions to help meet unmet medical needs and improve patient outcomes.

Cumulative Funding Raised Over Time ($)

Latest News

Oct 29, 2024 · www.mako.co.il

growth-positive

המהפכה בדרך: ה-AI עומד לשנות את תחום התרופות

ProPhet, a new Israeli startup, is leveraging artificial intelligence to significantly reduce the time and cost of discovering molecules that can be used as drugs. Founded by Tom Shani and Amitei Mordechai, the company emerged from AION Labs competitive startup challenge. ProPhet aims to revolutionize drug development by focusing on difficult-to-treat proteins and using AI to match molecules to proteins efficiently. The startup operates from AION Labs offices in Rehovot, Israel, benefiting from a collaborative ecosystem of scientists and entrepreneurs. AION Labs provides ProPhet with the necessary resources and connections to succeed in the pharmaceutical industry.

Partners

Oct 28, 2024 · www.prnewswire.com

growth-positive

AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery

ProPhet, a new startup launched by AION Labs, aims to revolutionize drug discovery by leveraging artificial intelligence to identify active small molecules. The company addresses the need to accelerate and enhance early drug discovery stages, particularly for challenging protein targets. ProPhet utilizes advanced machine learning technologies to develop novel algorithms for evaluating protein conformational states and screening small molecule libraries. AION Labs, a venture studio backed by major pharmaceutical companies and investors, provides ProPhet with resources and industry connections. The startups founding team includes experts in biology, chemistry, and computational science, positioning it well for success in the pharmaceutical industry.

Partners

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

4 Oppenheimer Building B 17th Floor, Rehovot, 7670104, Israel

Photos & Videos

No files yet

ProPhet Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info